1. The use of neurotoxins to lesion catecholamine-containing neurons to model clinical disorders;Breese,1998
2. Development of behavioral outcome measures for preclinical Parkinson’s research;Lindner,2000
3. Endogenous toxins as potential etiologic agents in Parkinson’s disease;Irwin,1995
4. Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson’s disease;Jellinger;J. Neural Transm.,1995
5. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine;Glinka;Eur. J. Pharmacol.,1995